H Volz

Summary

Affiliation: Friedrich Schiller University
Country: Germany

Publications

  1. ncbi request reprint High-energy phosphates in the frontal lobe correlate with Wisconsin Card Sort Test performance in controls, not in schizophrenics: a 31phosphorus magnetic resonance spectroscopic and neuropsychological investigation
    H P Volz
    Department of Psychiatry, University of Jena, Germany
    Schizophr Res 31:37-47. 1998
  2. ncbi request reprint Monoamine oxidase inhibitors. A perspective on their use in the elderly
    H P Volz
    Hans Berger Kliniken, Klinik fur Psychiatrie, Friedrich Schiller Universitat Jena, Germany
    Drugs Aging 13:341-55. 1998
  3. ncbi request reprint Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial
    H P Volz
    Psychiatric Department, Friedrich Schiller Universitat Jena, Philosophenweg 3, D 07740, Jena, Germany
    Eur Neuropsychopharmacol 10:211-7. 2000
  4. ncbi request reprint Supporting evidence for the model of cognitive dysmetria in schizophrenia--a structural magnetic resonance imaging study using deformation-based morphometry
    H Volz
    Psychiatric Department, University of Jena, Philosophenweg 3, D 07740, Jena, Germany
    Schizophr Res 46:45-56. 2000
  5. ncbi request reprint [Phytochemicals as means to induce sleep]
    H P Volz
    Psychiatrische Klinik der Friedrich Schiller Universit├Ąt Jena
    Z Arztl Fortbild Qualitatssich 95:33-4. 2001
  6. ncbi request reprint Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans
    U D Kuhn
    Institute of Clinical Pharmacology, Friedrich Schiller University, Jena, Germany
    Int J Clin Pharmacol Ther 45:36-46. 2007
  7. ncbi request reprint [Psychiatric comorbidity in somatic disorders. Psychophytopharmaceuticals are worth a try]
    H P Volz

    MMW Fortschr Med 143:62-6. 2001
  8. ncbi request reprint Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis
    M Ufer
    Institute of Pharmacology, University Hospital Schleswig Holstein, Kiel, Germany
    Pharmacoepidemiol Drug Saf 16:1153-60. 2007

Detail Information

Publications8

  1. ncbi request reprint High-energy phosphates in the frontal lobe correlate with Wisconsin Card Sort Test performance in controls, not in schizophrenics: a 31phosphorus magnetic resonance spectroscopic and neuropsychological investigation
    H P Volz
    Department of Psychiatry, University of Jena, Germany
    Schizophr Res 31:37-47. 1998
    ..This association was not found in schizophrenics, possibly due to the influence of neuroleptic medication or the disease process per se...
  2. ncbi request reprint Monoamine oxidase inhibitors. A perspective on their use in the elderly
    H P Volz
    Hans Berger Kliniken, Klinik fur Psychiatrie, Friedrich Schiller Universitat Jena, Germany
    Drugs Aging 13:341-55. 1998
    ..Although orthostatic hypotension occurs in most patients treated with traditional MAOIs, the incidence in elderly patients with depression does not appear to be greater than that reported with tricyclic antidepressants...
  3. ncbi request reprint Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial
    H P Volz
    Psychiatric Department, Friedrich Schiller Universitat Jena, Philosophenweg 3, D 07740, Jena, Germany
    Eur Neuropsychopharmacol 10:211-7. 2000
    ..A similar number of adverse events was noted in both groups. The results of this first-placebo-controlled study in somatoform disorders suggest efficacy of opipramol in this indication but need replication...
  4. ncbi request reprint Supporting evidence for the model of cognitive dysmetria in schizophrenia--a structural magnetic resonance imaging study using deformation-based morphometry
    H Volz
    Psychiatric Department, University of Jena, Philosophenweg 3, D 07740, Jena, Germany
    Schizophr Res 46:45-56. 2000
    ..This highlights the importance of this concept for future investigations...
  5. ncbi request reprint [Phytochemicals as means to induce sleep]
    H P Volz
    Psychiatrische Klinik der Friedrich Schiller Universit├Ąt Jena
    Z Arztl Fortbild Qualitatssich 95:33-4. 2001
    ..However, no sleep inducing potential of valerian was observed, only a certain positive effect on daytime mood. Therefore, the mentioned phytopharmacons cannot be recommended for the treatment of sleep disturbances...
  6. ncbi request reprint Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans
    U D Kuhn
    Institute of Clinical Pharmacology, Friedrich Schiller University, Jena, Germany
    Int J Clin Pharmacol Ther 45:36-46. 2007
    ..Thus, in this study the pharmacokinetics of reboxetine in relation to pharmacogenetics and the effects of reboxetine compared to paroxetine treatment on the CYP2D6 and CYP3A4 phenotype were analyzed in healthy control subjects...
  7. ncbi request reprint [Psychiatric comorbidity in somatic disorders. Psychophytopharmaceuticals are worth a try]
    H P Volz

    MMW Fortschr Med 143:62-6. 2001
    ..At present, no herbal preparation can be recommended for the treatment of sleep disorders, as no unequivocal proof of efficacy in patients with such problems has yet been established...
  8. ncbi request reprint Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis
    M Ufer
    Institute of Pharmacology, University Hospital Schleswig Holstein, Kiel, Germany
    Pharmacoepidemiol Drug Saf 16:1153-60. 2007
    ..Therefore, we have identified patterns and prevalence of antidepressant use among outpatients on a population-based scale in the German state of Baden-Wuerttemberg...